BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)

NCT04494646 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Bardoxolone Methyl
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]